Eli Lilly, Novo Nordisk near deal on weight loss drug costs
Digest more
Third-quarter results will be the first for Mike Doustdar who was tasked in August with turning around the Danish company's ...
See why Novo Nordisk A/S stock is primed for a rebound despite recent declines. Click for more about NVO growth catalysts in ...
2don MSN
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results